SERES THERAPEUTICS INC's ticker is and the CUSIP is 81750R952. A total of 3 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,272 | -95.5% | 14,400 | -90.9% | 0.00% | -100.0% |
| Q2 2023 | $757,778 | +131.2% | 158,200 | +173.7% | 0.00% | +100.0% |
| Q1 2023 | $327,726 | +56.1% | 57,800 | +54.1% | 0.00% | – |
| Q4 2022 | $210,000 | +191.7% | 37,500 | +234.8% | 0.00% | – |
| Q3 2022 | $72,000 | +176.9% | 11,200 | +45.5% | 0.00% | – |
| Q2 2022 | $26,000 | -93.3% | 7,700 | -85.9% | 0.00% | – |
| Q1 2022 | $389,000 | -63.1% | 54,700 | -56.7% | 0.00% | -100.0% |
| Q4 2021 | $1,053,000 | +45.6% | 126,400 | +21.7% | 0.00% | 0.0% |
| Q3 2021 | $723,000 | +65.8% | 103,900 | +467.8% | 0.00% | 0.0% |
| Q2 2021 | $436,000 | -56.6% | 18,300 | -62.5% | 0.00% | 0.0% |
| Q1 2021 | $1,005,000 | -30.5% | 48,800 | -17.3% | 0.00% | -66.7% |
| Q4 2020 | $1,446,000 | -59.9% | 59,000 | -53.7% | 0.00% | -72.7% |
| Q3 2020 | $3,607,000 | +904.7% | 127,400 | +69.0% | 0.01% | +450.0% |
| Q2 2020 | $359,000 | +1336.0% | 75,400 | +879.2% | 0.00% | – |
| Q2 2019 | $25,000 | +400.0% | 7,700 | +60.4% | 0.00% | – |
| Q4 2018 | $5,000 | +400.0% | 4,800 | +4700.0% | 0.00% | – |
| Q1 2018 | $1,000 | -94.1% | 100 | -94.1% | 0.00% | – |
| Q4 2017 | $17,000 | -34.6% | 1,700 | +6.2% | 0.00% | – |
| Q3 2017 | $26,000 | +116.7% | 1,600 | +45.5% | 0.00% | – |
| Q1 2017 | $12,000 | +1100.0% | 1,100 | +1000.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 100 | -50.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 14,400 | $34,272 | 0.00% |
| SIMPLEX TRADING, LLC | 64,500 | $153 | 0.00% |